comparemela.com

Latest Breaking News On - Hcw biologics inc - Page 1 : comparemela.com

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Up 13.2% in April

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Up 13.2% in April
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Biologics-inc
Exchange-commission
Nasdaq
Biologics-company-profile
Avantax-planning-partners-inc
Hcw-biologics-inc
Get-free-report
Planning-partners
Free-report

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Update

HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Approximately 0.1% of the shares of the company are […]

Biologics-company-profile
Biologics-inc
Nasdaq
Hcw-biologics-inc
Blackrock-inc
Avantax-planning-partners-inc
Hightower-advisors
Vanguard-group-inc
Get-free-report
Planning-partners
Tower-advisors

Rebecca Byam Bought 122% More Shares In HCW Biologics

HCW Biologics Inc. ( NASDAQ:HCWB ) shareholders (or potential shareholders) will be happy to see that the Chief.

Hcw-biologics
Nsider-transactions
Rebecca-byam
Hcw-biologics-inc
Share-price
Nsider-ownership

HCW Biologics (NASDAQ:HCWB) Stock Price Down 3.3%

HCW Biologics (NASDAQ:HCWB) Stock Price Down 3.3%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Blackrock
United-kingdom-general
United-kingdom
Vanguard-group-inc
Blackrock-inc
Hightower-advisors
Hcw-biologics-inc
Biologics-inc
Biologics-company-profile
Nasdaq
Get-free-report

Investigator Sponsor of HCW Biologics' (HCWB) Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Investigator Sponsor of HCW Biologics' (HCWB) Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Melissa-geller
Melissaa-geller
Jeffrey-miller
Masonic-cancer-center
Hcw-biologics-inc
National-killer
Department-of-obstetrics
Women-health
University-of-minnesota
Our-company
Annual-meeting
Division-director
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.